LEGN

Legend Biotech CorporationNASDAQHealthcare

$19.14+0.47%ClosedMarket Cap: $3.54B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-11	Morgan Stanley	—	Overweight	—
2026-03-11	RBC Capital	—	Outperform	—
2026-02-04	Barclays	—	Overweight	—
2026-01-22	TD Cowen	—	Hold	—
2026-01-22	HC Wainwright & Co.	—	Buy	—
2026-01-20	RBC Capital	—	Outperform	—
2025-12-17	Cantor Fitzgerald	—	Overweight	—
2025-12-12	Morgan Stanley	—	Overweight	—
2025-12-08	UBS	—	Buy	—
2025-11-13	Barclays	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$0.98	$1.82B	4
Sun Dec 31	$1.72	$2.12B	1
Mon Dec 31	$1.95	$2.53B	1
Tue Dec 31	$2.13	$2.77B	1